[18F] fluoroestradiol (FES) PET as a predictive measure for endocrine therapy in women with newly diagnosed metastatic breast cancer

被引：0
|
作者：
Linden, Hannah
Clark, Amy
Fowler, Amy
Novakova, Alena
Mankoff, David
Dehdashti, Farrokh
机构：
[1] Univ Washington, Seattle, WA 98195 USA
[2] Univ Penn, Philadelphia, PA 19104 USA
[3] Univ Wisconsin, Madison, WI 53706 USA
[4] Washington Univ, St Louis, MO 63130 USA
来源：
CANCER RESEARCH | 2018年 / 78卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
OT1-06-04
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Dynamic whole-body [18F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer
    Pedersen, Mette A.
    Munk, Ole L.
    Dias, Andre H.
    Steffensen, Johanne H.
    Moller, Anders L.
    Johnsson, Anna Lyhne
    Hansen, Kim Vang
    Bender, Dirk
    Jakobsen, Steen
    Busk, Morten
    Gormsen, Lars C.
    Tramm, Trine
    Borgquist, Signe
    Vendelbo, Mikkel H.
    EJNMMI RESEARCH, 2024, 14 (01)
  • [32] Discrepancy between [18F]-FES and [18F]-FDG PET/CT in ER-positive breast cancer with oesophageal metastasis
    Kiatkittikul, Peerapon
    Promteangtrong, Chetsadaporn
    Kunawudhi, Anchisa
    Siripongsatian, Dheeratama
    Chotipanich, Chanisa
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (09) : 3297 - 3298
  • [33] Dynamic whole-body [18F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer
    Mette A. Pedersen
    Ole L. Munk
    André H. Dias
    Johanne H. Steffensen
    Anders L. Møller
    Anna Lyhne Johnsson
    Kim Vang Hansen
    Dirk Bender
    Steen Jakobsen
    Morten Busk
    Lars C. Gormsen
    Trine Tramm
    Signe Borgquist
    Mikkel H. Vendelbo
    EJNMMI Research, 14
  • [34] The quest for improving the management of breast cancer by functional imaging: The discovery and development of 16α-[18F]fluoroestradiol (FES), a PET radiotracer for the estrogen receptor, a historical review
    Katzenellenbogen, John A.
    NUCLEAR MEDICINE AND BIOLOGY, 2021, 92 : 24 - 37
  • [35] Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
    Stokke, Caroline
    Norgaard, Jakob Nordberg
    Phillips, Hilde Feiring
    Sherwani, Alexander
    Nuruddin, Syed
    Connelly, James
    Schjesvold, Fredrik
    Revheim, Mona-Elisabeth
    MOLECULAR IMAGING AND BIOLOGY, 2022, 24 (05) : 842 - 851
  • [36] Comparison of [18F]fluciclovine and [18F]FDG PET/CT in Newly Diagnosed Multiple Myeloma Patients
    Caroline Stokke
    Jakob Nordberg Nørgaard
    Hilde Feiring Phillips
    Alexander Sherwani
    Syed Nuruddin
    James Connelly
    Fredrik Schjesvold
    Mona-Elisabeth Revheim
    Molecular Imaging and Biology, 2022, 24 : 842 - 851
  • [37] New approach to production and quality control of 16α-[18F] fluoroestradiol ([18F] FES: The effective functional molecular imaging probe for positive estrogen receptors breast cancer
    Dadashov, Z.
    Shukurov, R.
    Valiyev, M.
    Eryilmaz, K.
    Balashov, M.
    Novruzov, F.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S743 - S743
  • [38] 18F-Fluoroestradiol PET in the evaluation of probable oligometastatic breast cancer
    Denton, Matthew
    Taubman, Kim
    Sutherland, Tom
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2021, 65 (03) : 333 - 334
  • [39] Changes in estrogen binding to ER during endocrine therapy measured by serial [F-18]-fluoroestradiol positron emission tomography (FES PET)
    Linden, HM
    Link, JM
    Stekhova, S
    Livingston, RB
    Gralow, JR
    Ellis, GK
    Schubert, EK
    Peterson, LM
    Krohn, KA
    Mankoff, DA
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S237 - S237
  • [40] Molecular imaging with 18F-fluoroestradiol (18F-FES) to assess intrapatient heterogeneity in metastatic breast cancer (MBC): A European TRANSCAN program
    Gennari, A.
    Brain, E.
    Nanni, O.
    Couselo, E. Munoz
    Harbeck, N.
    Geiss, R.
    Rocca, A.
    Cortes, J.
    Degenhardt, T.
    Piccardo, A.
    Alberini, J-L.
    Matteucci, F.
    Decensi, A.
    Corradengo, D. S.
    Andreis, D.
    Marra, D.
    Gebhart, G.
    Brambati, C.
    Amadori, D.
    Bruzzi, P.
    ANNALS OF ONCOLOGY, 2017, 28
12345